Broad Institute: Improved Prime Editing System Makes Gene-Sized Edits in Human Cells at Therapeutic Levels
June 11, 2024
June 11, 2024
CAMBRIDGE, Massachusetts, June 11 (TNSres) -- The Broad Institute issued the following news on June 10, 2024:
* * *
The gene-editing approach uses prime editors and evolved enzymes called recombinases, and could pave the way to effective one-size-fits-all gene therapies for diseases such as cystic fibrosis.
* * *
Scientists at the Broad Institute of MIT and Harvard have improved a gene-editing technology that is now capable of inserting or subs . . .
* * *
The gene-editing approach uses prime editors and evolved enzymes called recombinases, and could pave the way to effective one-size-fits-all gene therapies for diseases such as cystic fibrosis.
* * *
Scientists at the Broad Institute of MIT and Harvard have improved a gene-editing technology that is now capable of inserting or subs . . .
